A detailed history of Royal Bank Of Canada transactions in Iridex Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 273 shares of IRIX stock, worth $379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273
Previous 30 810.0%
Holding current value
$379
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.97 - $3.53 $478 - $857
243 Added 810.0%
273 $0
Q1 2024

Nov 05, 2024

SELL
$2.35 - $3.1 $571 - $753
-243 Reduced 89.01%
30 $0
Q1 2024

May 15, 2024

SELL
$2.35 - $3.1 $291 - $384
-124 Reduced 80.52%
30 $0
Q4 2023

Feb 14, 2024

SELL
$1.9 - $3.28 $140 - $242
-74 Reduced 32.46%
154 $0
Q3 2023

Nov 14, 2023

SELL
$1.33 - $2.54 $31 - $60
-24 Reduced 9.52%
228 $0
Q2 2023

Aug 14, 2023

BUY
$1.76 - $2.43 $443 - $612
252 New
252 $0
Q3 2022

Nov 14, 2022

BUY
$2.41 - $3.41 $98 - $139
41 New
41 $0

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $22.2M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.